Skip to main content
Skip to main content
PNTG logo

The Pennant Group, Inc. (PNTG)

$39.40 +$0.88 (+2.28%) |Strong · 73
Signals are mixed — the Council read leans BUY (64/100) while the AI fundamental score is 73/100 (grade A); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Ken Griffin bearish.
MCap: $1.37B| P/E Ratio: 37.5| Vol: 202.0K| Target: $40.00 (+1.5%)| 52-wk range: $21.73 – $37.54
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

The Pennant Group, Inc. (PNTG) trades at $39.40 with AI Score 73/100 (Grade A). The Pennant Group, Inc. provides healthcare services, including home health, hospice, and senior living, across 14 states. Market cap: $1.37B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
The Pennant Group, Inc. provides healthcare services, including home health, hospice, and senior living, across 14 states. As of December 31, 2021, they operated 88 home health and hospice agencies and 54 senior living communities.

PNTG stock analysis for 2026: Analysts have set a consensus price target of $40.00 for The Pennant Group, Inc., suggesting 1.5% upside from the current price of $39.40. The AI MoonshotScore is 73/100, indicating a bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 64/100 · B+

PNTG: 4/7 perspectives are bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Bullish
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

The Pennant Group, Inc. (PNTG) Healthcare & Pipeline Overview

CEOBrent J. Guerisoli
Employees7000
HeadquartersEagle, ID, US
IPO Year2019

The Pennant Group, Inc. operates within the healthcare sector, focusing on home health, hospice, and senior living services across 14 states. With a market capitalization of $1.37B and a P/E ratio of 37.5, Pennant distinguishes itself through its integrated care model and geographic diversification in the fragmented healthcare services market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for PNTG?

The Pennant Group, Inc. presents a compelling investment thesis centered on its diversified healthcare service offerings and strategic geographic footprint. With a market capitalization of $1.37B and a P/E ratio of 37.5, Pennant's growth is underpinned by the increasing demand for home health, hospice, and senior living services. Key value drivers include the expansion of its agency and community network, enhanced operational efficiencies, and the ability to capitalize on favorable demographic trends. A gross margin of 14.8% and a profit margin of 3.0% indicate areas for potential improvement through economies of scale and optimized service delivery. Upcoming catalysts include continued acquisitions and organic growth initiatives, while potential risks involve regulatory changes and competitive pressures within the healthcare sector.

Based on FMP financials and quantitative analysis

PNTG Key Highlights

  • Market capitalization of $1.37B, reflecting investor confidence in Pennant's growth strategy.
  • P/E ratio of 37.5, indicating a premium valuation relative to earnings.
  • Gross margin of 14.8%, highlighting the need for improved operational efficiency.
  • Profit margin of 3.0%, suggesting opportunities for margin expansion through cost management.
  • Operates 88 home health and hospice agencies and 54 senior living communities across 14 states, showcasing geographic diversification.

Who Are PNTG's Competitors?

PNTG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
LHCG LHC Group, Inc. $169.81 +0.00% $5.29B 45
AMED Amedisys, Inc. $100.99 +0.01% $3.32B 50
FIVE Five Below, Inc. $176.81 -3.08% $9.78B 72
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
SLHGP Skylight Health Group Inc. $12.00 -5.88% 61
TOI The Oncology Institute, Inc. $5.45 +3.22% $544.91M 61

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PNTG's Key Strengths?

  • Diversified service offerings across home health, hospice, and senior living.
  • Geographic presence in multiple states.
  • Experienced management team with a track record of growth.
  • Strong relationships with healthcare providers and payers.

What Are PNTG's Weaknesses?

  • Relatively low gross and profit margins compared to industry peers.
  • High reliance on government reimbursements.
  • Exposure to regulatory changes and compliance risks.
  • Competition from larger, more established players.

What Could Drive PNTG Stock Higher?

  • Continued acquisitions of home health, hospice, and senior living agencies to expand market presence.
  • Implementation of technology solutions to improve operational efficiency and patient care.
  • Expansion of value-based care initiatives to enhance reimbursement rates and patient outcomes.

What Are the Key Risks for PNTG?

  • Rich valuation — a P/E of 37.5 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
  • Changes in government reimbursement policies could negatively impact revenue and profitability.
  • Increased competition from other healthcare providers could erode market share.
  • Rising labor costs and workforce shortages could strain financial performance.

What Are the Growth Opportunities for PNTG?

  • Expansion of Home Health and Hospice Services: The market for home health and hospice services is projected to grow significantly, driven by the aging population and increasing preference for in-home care. Pennant can capitalize on this trend by expanding its agency network and service offerings in existing and new geographic markets. This expansion can be achieved through strategic acquisitions and organic growth initiatives, enhancing its market share and revenue streams. The timeline for this growth is ongoing, with continuous efforts to identify and integrate new agencies.
  • Enhancement of Senior Living Services: The demand for senior living communities is also on the rise, driven by the increasing number of seniors requiring residential accommodations and assistance with daily living activities. Pennant can enhance its senior living services by expanding its community network, improving the quality of care, and offering specialized programs tailored to the needs of seniors. This includes investing in facility upgrades, staff training, and innovative care models. The timeline for this growth is ongoing, with a focus on long-term sustainability and resident satisfaction.
  • Strategic Acquisitions: Pennant has a proven track record of successfully acquiring and integrating home health, hospice, and senior living agencies and communities. Strategic acquisitions provide opportunities to expand its geographic footprint, enhance its service offerings, and achieve economies of scale. Pennant can continue to pursue strategic acquisitions in attractive markets, leveraging its operational expertise and financial resources to drive growth and profitability. The timeline for this growth is ongoing, with a focus on identifying and evaluating potential acquisition targets.
  • Technological Innovation: Investing in technological innovation can improve operational efficiency, enhance the quality of care, and differentiate Pennant from its competitors. This includes implementing electronic health records (EHRs), telehealth solutions, and data analytics tools to streamline workflows, improve patient outcomes, and optimize resource allocation. By leveraging technology, Pennant can reduce costs, improve service delivery, and gain a competitive advantage. The timeline for this growth is ongoing, with a focus on continuous improvement and innovation.
  • Value-Based Care Initiatives: As the healthcare industry shifts towards value-based care models, Pennant can capitalize on this trend by participating in accountable care organizations (ACOs) and other value-based payment arrangements. By demonstrating its ability to deliver high-quality care at a lower cost, Pennant can attract new patients, improve its reimbursement rates, and enhance its reputation. This includes implementing care coordination programs, focusing on preventive care, and measuring patient outcomes. The timeline for this growth is ongoing, with a focus on aligning incentives and improving care delivery.

What Opportunities Does PNTG Have?

  • Expansion into new geographic markets.
  • Strategic acquisitions of complementary businesses.
  • Development of innovative care models and technologies.
  • Participation in value-based care initiatives.

What Threats Does PNTG Face?

  • Changes in government reimbursement policies.
  • Increased competition from other healthcare providers.
  • Rising labor costs and workforce shortages.
  • Economic downturns that could impact demand for services.

What Are PNTG's Competitive Advantages?

  • Geographic diversification across 14 states reduces reliance on any single market.
  • Integrated service offerings across home health, hospice, and senior living provide comprehensive care solutions.
  • Established relationships with healthcare providers and payers enhance market access.

What Does PNTG Do?

The Pennant Group, Inc., incorporated in 2019 and headquartered in Eagle, Idaho, provides a range of healthcare services across the United States. The company operates through two primary segments: Home Health and Hospice Services, and Senior Living Services. The Home Health and Hospice Services segment delivers clinical services such as nursing, speech therapy, occupational therapy, physical therapy, medical social work, and home health aide services. Additionally, it offers hospice care, including clinical care, education, and counseling for terminally ill patients and their families, addressing their physical, spiritual, and psychosocial needs. The Senior Living Services segment provides residential accommodations, activities, meals, housekeeping, and assistance with daily living activities to seniors who are either independent or require support. As of December 2021, Pennant operated 88 home health and hospice agencies and 54 senior living communities with 4,127 units across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. Pennant's integrated approach aims to provide comprehensive care solutions, positioning it as a key player in the expanding healthcare services market.

What Products and Services Does PNTG Offer?

  • Provides home health services, including nursing and therapy.
  • Offers hospice care for terminally ill patients and their families.
  • Operates senior living communities with residential accommodations.
  • Provides assistance with activities of daily living for seniors.
  • Offers clinical care, education, and counseling services.
  • Provides medical social work and home health aide services.

How Does PNTG Make Money?

  • Generates revenue from home health and hospice services through Medicare, Medicaid, and private insurance reimbursements.
  • Earns revenue from senior living services through resident fees and service charges.
  • Expands through strategic acquisitions and organic growth of agencies and communities.

What Industry Does PNTG Operate In?

The Pennant Group, Inc. operates in the healthcare services industry, which is characterized by increasing demand driven by an aging population and a growing preference for home-based and community-based care. The market is fragmented, with numerous regional and national players. Pennant's focus on integrated home health, hospice, and senior living services positions it to capitalize on the trend towards comprehensive care solutions. The industry is also subject to regulatory scrutiny and reimbursement pressures, requiring companies to maintain high standards of compliance and operational efficiency.

Who Are PNTG's Key Customers?

  • Seniors requiring residential accommodations and assistance with daily living.
  • Terminally ill patients and their families seeking hospice care.
  • Individuals requiring home health services due to illness, injury, or disability.
AI Confidence: 73% Updated: May 10, 2026

ROE 9%Key Financial Metrics

Return on equity for The Pennant Group, Inc. stands at 9.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.2%, showing how much profit it generates from its asset base. PNTG trades at a trailing price-to-earnings ratio of 37.53, above the Healthcare sector average of ~23x. Its free cash flow yield is 3.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.19 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.3%, the inverse of the P/E and a quick read on earnings relative to price.

The Pennant Group, Inc. (PNTG) Valuation Context

Valued at $1.37B, PNTG is classified as a small-cap stock. Relative to its peer group, PNTG's quantitative score of 73/100 is above the peer average of 59/100.

Company Profile

The Pennant Group, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Eagle, US. The company is led by CEO Brent J. Guerisoli. PNTG has traded publicly since 2019.

F-Score 5/9Financial Health

The Pennant Group, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.83 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project The Pennant Group, Inc. revenue of about $1.17B for fiscal 2026, with EPS near $1.35. The estimate reflects 5 contributing analysts.

Net buyingInsider Activity

Over the past six months, The Pennant Group, Inc. insiders filed 15 SEC Form 4 transactions — 6 sales and 9 purchases. On net that is roughly 28K shares acquired (about $158K) — insiders putting money in tends to read as conviction.

PNTG Financials

Fundamental Snapshot

Revenue Growth (FY)
+36.3%
Net Income Growth (FY)
+31.1%
EPS Growth (FY)
+19.4%
Free Cash Flow Growth (FY)
-13.2%
P/E (TTM)
44.4
Return on Equity (TTM)
+9.2%
Current Ratio
1.2
EV/EBITDA (TTM)
29.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying signals confidence from those closest to the company.
  • Positive community sentiment suggests strong belief in PNTG's long-term strategy.
  • Market perception sees growth potential in the home health and hospice care sector.
  • Bullish community views highlight PNTG's ability to navigate regulatory changes.

Bear Case

  • Lack of significant news flow might indicate a period of stagnation for PNTG.
  • Bearish community views express concern over increasing competition in the healthcare space.
  • Insider selling, even if minor, can sometimes trigger negative market perception.
  • General market uncertainty could dampen investor enthusiasm for smaller-cap stocks like PNTG.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

PNTG Latest News

PNTG Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PNTG.

Price Targets

Consensus target: $40.00

PNTG MoonshotScore

73/100

What does this score mean?

The MoonshotScore rates PNTG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest The Pennant Group, Inc. Analysis

Leadership: Brent J. Guerisoli

Chief Executive Officer

Brent J. Guerisoli serves as the Chief Executive Officer of The Pennant Group, Inc. His career spans various leadership roles within the healthcare industry, demonstrating expertise in operational management and strategic development. Guerisoli's background includes a strong emphasis on improving patient care and driving organizational growth. He has been instrumental in implementing innovative healthcare solutions and fostering a culture of excellence within Pennant. His leadership is characterized by a focus on sustainable growth and enhanced shareholder value.

Track Record: Under Brent J. Guerisoli's leadership, The Pennant Group, Inc. has experienced significant growth in its home health, hospice, and senior living segments. He has overseen the successful integration of numerous acquisitions, expanding the company's geographic footprint and service offerings. Guerisoli has also focused on improving operational efficiencies and enhancing the quality of care, contributing to Pennant's strong reputation in the healthcare industry.

The Pennant Group, Inc. Healthcare Stock: Key Questions Answered

What does The Pennant Group, Inc. do?

The Pennant Group, Inc. operates in the healthcare services sector, providing a range of services including home health, hospice, and senior living. The company's business model focuses on delivering comprehensive care solutions to patients and residents across 14 states. Pennant generates revenue through Medicare, Medicaid, and private insurance reimbursements for its home health and hospice services, as well as through resident fees and service charges for its senior living communities. The company expands its market position through strategic acquisitions and organic growth of its agencies and communities.

What do analysts say about PNTG stock?

Analyst coverage of The Pennant Group, Inc. (PNTG) typically focuses on its growth prospects within the healthcare services industry, particularly in the home health, hospice, and senior living segments. Key valuation metrics such as P/E ratio and market capitalization are closely monitored to assess the company's financial performance and growth potential. Analyst consensus generally reflects expectations for continued revenue growth driven by strategic acquisitions and organic expansion. However, potential risks such as regulatory changes and competitive pressures are also considered in their evaluations.

What are the main risks for PNTG?

The Pennant Group, Inc. faces several key risks inherent to the healthcare services industry. Changes in government reimbursement policies, particularly those related to Medicare and Medicaid, could significantly impact the company's revenue and profitability. Increased competition from other healthcare providers, including larger and more established players, could erode market share. Rising labor costs and workforce shortages, especially for nurses and other healthcare professionals, could strain financial performance. Additionally, regulatory compliance and potential litigation risks are ongoing concerns for the company.

What are the key factors to evaluate for PNTG?

The Pennant Group, Inc. (PNTG) holds an AI score of 73/100 (high). P/E: 37.5x vs the S&P 500's ~20-25x. Analysts target $40.00 (+2%). Not financial advice.

How frequently does PNTG data refresh on this page?

PNTG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven PNTG's recent stock price performance?

The Pennant Group, Inc. (PNTG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across home health, hospice, and senior living. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PNTG overvalued or undervalued right now?

The Pennant Group, Inc. (PNTG) trades at 37.5x earnings. Analysts target $40.00 (+2%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying PNTG?

Before investing in The Pennant Group, Inc. (PNTG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2021 and 2026-05-10. Future performance may vary.
Data Sources

Popular Stocks